Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of human placenta-derived mesenchymal stem cell hydrogel for Crohn's perianal fistulas
ChiCTR2100046546Phase 2Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jun 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of human placenta mesenchymal stromal cells in Crohn's disease (2 arms), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Primary endpoint: Fistula clinical response. Started Jun 2021; status: recruiting.
02
Drugs
human placenta mesenchymal stromal cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on ChiCTR2100046546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046546.